bims-axbals Biomed News
on Axonal biology and ALS
Issue of 2026–11–01
38 papers selected by
TJ Krzystek



  1. Biomolecules. 2026 Oct 09. pii: 1470. [Epub ahead of print]16(10):
      Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the loss of motor neurons and widespread neural dysfunction. Loss of serotonin (5-HT) signaling and TAR DNA-binding protein 43 (TDP-43) dysfunction have both been identified as contributing factors to disease progression, although their relationship has yet to be fully defined. The objective of this review was to assess whether any mechanistic links exist between serotonergic dysfunction and TDP-43 proteinopathy in ALS. A scoping review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. Databases were queried for the peer-reviewed literature concerning ALS pathophysiology, 5-HT, and TDP-43 (1946 to January 2026). Articles were screened and data independently extracted by two reviewers, which were subsequently synthesized qualitatively (n = 14). The current literature suggests that serotonergic dysfunction can be identified early in ALS pathology, indicated by decreased 5-HT concentration, degeneration of raphe projections, and changes in receptor activity. TDP-43 proteinopathy is a defining characteristic of ALS progression, characterized by cytoplasmic mislocalization and aggregation of TDP-43. Additionally, studies have identified bidirectional links between these dysfunctions: TDP-43 impairs serotonergic transmission, and 5-HT deficiency may drive pathological TDP-43 aggregation. Many mechanisms affected by both serotonergic and TDP-43 dysfunction are associated with disease progression including excitotoxicity, metabolic disturbances, and network hyperexcitability. Despite this, there is a lack of direct experimental evidence elucidating connections between these pathologies. Serotonergic dysfunction and TDP-43 proteinopathy may be linked by shared mechanisms in ALS, though specific causality has not been identified. Further research should aim to clarify the connection between these processes and discover therapeutic targets.
    Keywords:  TAR DNA-binding protein 43 (TDP-43); amyotrophic lateral sclerosis (ALS); protein aggregation; serotonergic dysfunction; serotonin (5-HT); serotonin receptor (5-HTR)
    DOI:  https://doi.org/10.3390/biom16101470
  2. Front Neurol. 2026 ;17 1891393
      The accumulation of α-synuclein (α-syn) in the form of Lewy bodies and Lewy neurites is a neuropathological hallmark of Parkinson's disease (PD) and is closely associated with disease progression. Targeting the autophagy pathway to enhance the clearance of α-syn aggregates therefore represents a promising therapeutic strategy. In the present study, we conducted high-throughput screening using rat embryonic primary neurons, followed by validation of the identified compounds in human induced pluripotent stem cell (iPSC)-derived neurons. We identified dibucaine, a local anesthetic, as a compound that induced autophagic flux in neuronal models. In human iPSC-derived dopaminergic neurons from a patient with PD carrying an SNCA duplication, dibucaine reduced cellular levels of Ser129-phosphorylated α-synuclein (pS129 α-syn). In SH-SY5Y cells, dibucaine increased 5'-AMP-activated protein kinase (AMPK) Thr172 phosphorylation. LY364947 partially attenuated dibucaine-induced LC3-II accumulation in the iPSC-derived neurons through an unidentified mechanism. Although the requirement for AMPK and the mechanism underlying the reduction in pS129 α-syn remain unresolved, our findings show that dibucaine induces autophagic flux and reduces pS129 α-syn levels in disease-relevant human neurons.
    Keywords:  Parkinson’s disease; alpha-synuclein; autophagy; dibucaine; neurodegenerative disease; protein aggregation
    DOI:  https://doi.org/10.3389/fneur.2026.1891393
  3. F1000Res. 2026 ;15 632
      The SMPD1 gene encodes the acid sphingomyelinase (ASM) protein, a lysosomal enzyme essential for hydrolysing sphingomyelin into ceramide and phosphorylcholine, a key step in lipid metabolism and membrane homeostasis. Here we have characterized nine ASM commercial antibodies for western blot and immunoprecipitation using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While the use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.
    Keywords:  ASM; Acid sphingomyelinase; P17405; SMPD1; Sphingomyelin phosphodiesterase; antibody characterization; antibody validation; immunofluorescence; immunoprecipitation; western blot
    DOI:  https://doi.org/10.12688/f1000research.178749.1
  4. Brain Res. 2026 Oct 27. pii: S0006-8993(26)00480-4. [Epub ahead of print] 150618
      TAR DNA-binding protein 43 (TDP-43) pathology is a defining feature of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although TDP-43 dysfunction has traditionally been studied through a neuron-centric framework, increasing evidence demonstrates that astrocytes, microglia, and oligodendrocytes are also directly affected and actively contribute to disease progression. In this review, we examine how TDP-43 dysfunction disrupts lineage-specific glial homeostatic programs and promotes distinct pathological state transitions across major glial populations. In astrocytes, TDP-43 dysfunction impairs neurotransmitter regulation, metabolic and neuronal support, RNA homeostasis, and secretory signaling while promoting inflammatory and antiviral-like states. In microglia, altered TDP-43 disrupts inflammatory regulation, phagocytosis, lysosomal function, lipid metabolism, and stage-dependent protective responses. In oligodendrocytes, TDP-43 dysfunction compromises RNA processing, lineage maintenance, lipid metabolism, myelin integrity, and long-term axonal support. Together, these findings suggest that glial TDP-43 dysfunction cannot be reduced to a single generalized form of reactivity but instead reflects the breakdown of distinct cell type-specific identities required to maintain central nervous system homeostasis. A cross-glial framework integrating cell-autonomous dysfunction, non-cell-autonomous signaling, disease stage, and genetic context may therefore provide a more complete understanding of TDP-43 proteinopathy and its contribution to neurodegeneration across the ALS-FTD spectrum.
    Keywords:  Amyotrophic lateral sclerosis; Astrocytes; Frontotemporal dementia; Glia; Microglia; Oligodendrocytes; TDP-43
    DOI:  https://doi.org/10.1016/j.brainres.2026.150618
  5. Proc Natl Acad Sci U S A. 2026 Nov 03. 123(44): e2602106123
      In neurons, the endoplasmic reticulum (ER) forms an extensive network that establishes membrane contact sites (MCSs) with various organelles including the plasma membrane (PM). While MCSs are known to regulate lipid exchange and Ca2+ signaling, their specific roles in synaptic transmission remain poorly understood. Here, we demonstrate that the ER-resident proteins VAPA and VAPB are essential for organizing presynaptic Ca2+ exchange and mobilizing synaptic vesicles. We show that the loss of VAP impairs Ca2+ loading into both the ER and mitochondria during electrical activity. This regulation occurs primarily through VAP interactions with voltage-gated potassium (Kv2) channels at the PM. Our data suggest that the Kv2-VAP complex organizes presynaptic Ca2+ signaling outside the active zone. Without this scaffold, vesicle mobilization for exocytosis is strongly impaired and a larger fraction remains trapped in the reserve pool. These findings reveal a role for Kv2-VAP MCSs in coordinating organelle Ca2+ signaling and the synaptic vesicle cycle.
    Keywords:  calcium; endoplasmic reticulum; presynaptic; synaptic transmission; vesicles
    DOI:  https://doi.org/10.1073/pnas.2602106123
  6. Rinsho Ketsueki. 2026 ;67(9): 1145-1149
      Advances in induced pluripotent stem cell (iPSC) technology have enabled the establishment of patient-derived disease models, greatly accelerating research on disease mechanisms and drug discovery. Drug repositioning, which applies existing drugs to new indications, has emerged as an efficient therapeutic development strategy that reduces both development time and cost. This review summarizes recent progress in disease modeling and therapeutic research using iPSCs, focusing on amyotrophic lateral sclerosis (ALS). Motor neurons differentiated from ALS patient-derived iPSCs successfully recapitulated disease phenotypes and enabled compound screening. Using this platform, the Src/c-Abl inhibitor bosutinib was identified as a promising therapeutic candidate. Bosutinib promoted autophagy, reduced abnormal protein accumulation, and suppressed motor neuron degeneration in vitro and in vivo. Based on these findings, investigator-initiated clinical trials were conducted, demonstrating acceptable safety and suggesting potential efficacy in ALS patients. Furthermore, integration of iPSC-based analyses with biomarkers such as neurofilament light chain enabled patient stratification and suggested the feasibility of personalized therapeutic approaches. Future integration of iPSC models with artificial intelligence, genomic analysis, and real-world clinical data is expected to further enhance predictive precision and accelerate translational research. iPSC-based drug discovery therefore represents a promising platform for developing novel therapies for neurodegenerative diseases.
    Keywords:  Amyotrophic lateral sclerosis; Drug repositioning; Src/c-Abl pathway; iPSC-based drug discovery and development
    DOI:  https://doi.org/10.11406/rinketsu.67.1145
  7. Mol Med. 2026 Sep 22. pii: 197. [Epub ahead of print]32(1):
       BACKGROUND: The basal ganglia (BG) comprise a critical neural system involved in voluntary motor coordination and balance. While small animal models have been useful to improve our basic understanding of the development and function of neural systems, they are relatively low-throughput, lack human-specific genomic and target specificity, and fail to recapitulate critical anatomical features such as centimeter-scale axon tracts. Accordingly, bioengineered models replicating human systems-level features such as neuronal constituents, neurophysiology, and long-distance connectivity would be valuable to study BG circuit development, maturation, and function, as well as responses to neurotrauma and neurodegenerative diseases. To address this unmet need, we report the fabrication of a three-dimensional tissue engineered nigrostriatal pathway (TE-NSP) featuring human induced pluripotent stem cell (iPSC) derived dopaminergic (DA) neurons and centimeter-scale axon tracts that were maintained as a long-term in vitro model of key components of BG circuitry.
    METHODS: TE-NSPs were fabricated using hyaluronic acid hydrogel microcolumns filled with collagen-laminin solution that were used to seed two types of neuronal aggregates, namely, human iPSC-derived DA and striatal neurons. These TE-NSPs featuring the co-culture of DA and striatal neurons were characterized for phenotypic stability, axonal growth, synaptic integration, and viability over 6 months in vitro.
    RESULTS: Our results demonstrate anatomically-relevant 3 cm long TE-NSPs with discrete 3D compartmentalized structures connected via > 2 cm long dopaminergic axon tracts. The TE-NSPs exhibited survival up to 6 months in vitro with dense TH + axon tracts and high cell viability. Immunohistochemistry revealed the widespread expression of mature synaptic markers within the TE-NSPs at 180 days in vitro featuring similarity with native in vivo rat striatal tissue. These long-lived TE-NSPs showed robust axonal outgrowth and innervation within the striatal compartment of the engineered tissue.
    CONCLUSIONS: We have established a mature living human iPSC-derived neural microtissue that recapitulates human-relevant anatomical connections and models a key component of the BG circuitry. This bioengineered human microtissue model could serve as a powerful platform for studying neural systems development, function, and neurodegenerative sequelae such as Parkinson's disease, while also providing the basis for an implantable microtissue for circuit-level reconstruction following neurotrauma or neurodegenerative disease.
    Keywords:  Axonal pathway; Living scaffold; Neurodegeneration; Parkinson’s disease; Tissue engineering
    DOI:  https://doi.org/10.1186/s10020-026-01650-x
  8. Cell. 2026 Oct 28. pii: S0092-8674(26)01210-9. [Epub ahead of print]
      Huntington's disease (HD) is caused by CAG expansion in the huntingtin gene (HTT), yet how somatic repeat instability and HTT inclusions relate to selective cell loss in the human brain remains unclear. We have developed a multimodal spatial transcriptomics approach that enables the definition of transcriptional programs with subcellular resolution, somatic CAG repeat lengths, and eight other pathology markers, including HTT inclusions, in every cell of intact brain sections. Imaging 428,173 cells in the control and HD cortex revealed the selective vulnerability of layer 5-6 (L5-6) near-projecting (NP) neurons and L6b deep-layer excitatory neurons, which undergo a >50% loss that is closely linked to large somatic repeat expansions (>450 ± 55 CAGs). Intranuclear inclusions were most prevalent at intermediate somatic repeat expansions (250-350 CAGs) and were associated with broader transcriptional changes than somatic repeat expansion alone. These data provide a comprehensive resource and establish a general framework for connecting repeat expansion and protein pathology across diverse cell types.
    Keywords:  Huntington’s disease; multimodal spatial transcriptomics; neurodegeneration; protein aggregation; somatic repeat expansion; trinucleotide repeats
    DOI:  https://doi.org/10.1016/j.cell.2026.09.064
  9. Traffic. 2026 Dec;pii: e70057. [Epub ahead of print]27(4):
      At membrane contact sites (MCSs) between the endoplasmic reticulum (ER) and endolysosomal compartments, the Protrudin-PDZD8 complex promotes the maturation of endosomes into lysosomes, a process accompanied by acidification. Endosomal maturation is closely associated with both lysosomal acidification and calcium signaling; however, the molecular mechanisms linking the Protrudin-PDZD8 complex to these processes remain unclear. Here, we identified TMEM55B, a lysosome-localized protein, as a binding partner of the Protrudin-PDZD8 complex. TMEM55B has been reported to interact with the v-ATPase complex, suggesting a role in lysosomal function. Suppression of TMEM55B expression reduced the fluorescence of a lysosomal acidification probe, suggesting impaired lysosomal acidification. In addition, TMEM55B depletion attenuated lysosomal Ca2+ release and reuptake and reduced ATP-induced Ca2+ responses in the ER. These findings suggest impaired calcium-induced calcium release (CICR) at ER-lysosome MCSs. By contrast, mitochondrial Ca2+ dynamics were unaffected. Together, these results identify TMEM55B as a factor involved in maintaining lysosomal homeostasis and regulating calcium dynamics. Our findings suggest that TMEM55B cooperates with the Protrudin-PDZD8 complex to contribute to the regulation of lysosomal function at ER-lysosome MCSs.
    Keywords:  PDZD8; TMEM55B; calcium signaling; lysosome; membrane contact site
    DOI:  https://doi.org/10.1111/tra.70057
  10. Neural Regen Res. 2026 Oct 24.
       ABSTRACT: Amyotrophic lateral sclerosis is a progressive neurodegenerative disease characterized by the degeneration of both upper and lower motor neurons. Recent advances in human-induced pluripotent stem cell-derived brain organoids offer an innovative platform to model amyotrophic lateral sclerosis in a human-specific context. These three-dimensional organoid systems allow for the study of neuronal circuit-level dysfunction, which is central to amyotrophic lateral sclerosis pathogenesis, by incorporating multiple neuronal subtypes and supporting glial populations. In particular, the integration of region-specific brain organoids into assembloid models has enabled the reconstruction of functional long-range projections and cortico-motor circuits, closely resembling human neural connectivity. This review summarizes the generation and application of human induced pluripotent stem cell-derived brain organoids for amyotrophic lateral sclerosis research, with a focus on the reconstruction of neural circuits, multi-omics profiling, and functional assays. We also discuss how organoid systems can be leveraged for drug discovery and personalized medicine in amyotrophic lateral sclerosis, highlighting their potential to unveil human-specific disease mechanisms. Lastly, we address the current challenges and future directions for improving the physiological relevance of organoid models in amyotrophic lateral sclerosis research.
    Keywords:  amyotrophic lateral sclerosis; assembloids; brain organoid; motor neuron disease; neural circuits
    DOI:  https://doi.org/10.4103/NRR.NRRONLINE-D-26-00781
  11. J Cell Biol. 2026 Dec 07. pii: e202606052. [Epub ahead of print]225(12):
      Recent work from two independent studies has uncovered mitochondria as a previously unrecognized proton source driving lysosomal acidification. In this Viewpoint, we summarize these findings, examine the associated proteins and functional mechanisms, and discuss their relevance to disease.
    DOI:  https://doi.org/10.1083/jcb.202606052
  12. CNS Neurosci Ther. 2026 Oct;pii: e71205. [Epub ahead of print]32(10):
       AIMS: Deanna Protocol (DP) is an anaplerotic, mechanism-based therapy designed to address impaired cellular energy flux. The present study aims to investigate the effects of DP in treating Alzheimer's disease (AD) by using cortical neurons derived from AD patient iPSCs carrying a PSEN1 mutation, while cortical neurons differentiated from iPSCs of a healthy subject serve as control.
    METHODS: PSEN1 cortical neurons were treated with DP acutely (24 h) and chronically (1-3 weeks). The effect of DP was assessed by utilizing TMRE assay for mitochondrial function, immunofluorescent staining for AD neuron morphological pathology, whole cell patch clamp for neuron electrophysiological property, and microelectrode array (MEA) analysis of long-term potentiation (LTP) for neurocircuit function.
    RESULTS: PSEN1 cortical neurons demonstrated impaired mitochondrial function, elevated pathological biomarkers, reduced neurite complexity, altered electrophysiology, and decreased LTP. DP treatment significantly ameliorated all these phenotypes.
    CONCLUSION: This study, while confirming iPSC-PSEN1 cortical neurons as a valid AD model, demonstrated the efficacy of DP on ameliorating structural and functional pathologies in AD neurons. It highlights that targeting energy production could be an effective approach in treating neurodegeneration in AD and suggests its potential efficacy in other neurodegenerative diseases.
    Keywords:  Alzheimer's disease; Deanna Protocol; cellular energy; cortical neurons; iPSC; long‐term potentiation; microelectrode array
    DOI:  https://doi.org/10.1002/cns.71205
  13. bioRxiv. 2026 Oct 20. pii: 2026.10.01.755968. [Epub ahead of print]
      Spontaneous spinal cord regeneration is an endogenous process operational in diverse vertebrate and select mammalian species. Yet despite resulting in functional regeneration, axonal regrowth dynamics as well as underlying molecular programs are largely unknown. Live-cell imaging following laser axotomy of individual zebrafish spinal cord M-cell axons reveals a time-sensitive multistep process. From a genetic screen we uncover previously unrecognized roles for two evolutionary conserved genes, celsr3 and huntingtin (htt) in spontaneous spinal cord regeneration. Specifically, we find that htt is critical to initiate a transcriptional injury response in regenerating M-cells, enabling their axon to traverse the injury site. Once axons cross the injury site celsr3 functions to increase growth rates, while both celsr3 and htt function to sustain long-range axonal growth. Moreover, we show that htt is dispensable for optic nerve and peripheral motor neuron regeneration, and that reducing soma-to-injury site distance in htt mutant M-cell axons partially restores regeneration, demonstrating a selective role in long-range CNS axon regeneration. Consistent with a transport-based mechanism, genetic knockdown of htt-associated axonal transport proteins recapitulates the htt mutant regeneration phenotype. Combined, our results provide compelling evidence for a time and distance-sensitive multistep molecular framework in which celsr3 dependent growth rate modulation and htt dependent axonal transport promote spontaneous, long-range spinal cord regeneration.
    DOI:  https://doi.org/10.64898/2026.10.01.755968
  14. Cells. 2026 Oct 12. pii: 1850. [Epub ahead of print]15(20):
      TAR DNA-binding protein 43 (TDP-43) pathology is a major contributor to cognitive decline in Alzheimer's disease (AD), yet the cellular substrates and circuit-level consequences of its limbic accumulation remain poorly defined. Here, we combined multiplex immunofluorescence with 3D Artificial Intelligence (AI)-based object detection and quantitative colocalization to map phosphorylated TDP-43 (pTDP-43) across neuronal subtypes in the amygdala, hippocampal subfields, and entorhinal cortex (ERC) in human AD, AD with Lewy body disease (AD-LBD), and primary age-related tauopathy (PART). Across 15 deeply phenotyped cases, pTDP-43 showed preferential accumulation in neuromodulatory noradrenergic neurons, with more limited involvement of glutamatergic terminals and cholinergic populations. Noradrenergic neurons marked by dopamine β-hydroxylase (DβH) demonstrated extensive colocalization with pTDP-43 across regions, correlating with APOE genotype, amyloid burden, and tau staging in this cross-sectional cohort, suggesting that neuromodulatory circuits might represent a major convergence point for AD-related molecular stressors. Dopaminergic (tyrosine hydroxylase (TH)) and cholinergic (choline acetyltransferase (ChAT)) neurons showed more restricted but pathology-dependent involvement, with LBD consistently showing lower pTDP-43 burden across multiple transmitter systems. Glutamatergic vesicular glutamate transporter-1 (VGLUT1)-positive neurons and terminals exhibited minimal colocalization except in PART. Principal component (PCA) and hierarchical clustering analyses (HCA) integrating pTDP-43 colocalization with neuropathologic staging metrics (A, B, C, Thal, Braak, LBD) reliably separated PART, AD-TDP, and AD-TDP-LBD groups, with LBD emerging as a dominant modifier of cellular vulnerability. Together, these findings point out that TDP-43 pathology in AD preferentially targets neuromodulatory circuits, is strongly shaped by coexisting synucleinopathy, and provides a cell-type-resolved framework for understanding how TDP-43 contributes to limbic network dysfunction in neurodegeneration.
    Keywords:  Alzheimer’s disease (AD); Artificial Intelligence (AI); Lewy body disease (LBD); TAR DNA-binding protein 43 (TDP-43); cholinergic; glutamatergic; noradrenergic; primary age-related tauopathy (PART)
    DOI:  https://doi.org/10.3390/cells15201850
  15. Cell Rep. 2026 Oct 29. pii: S2211-1247(26)01285-4. [Epub ahead of print]45(11): 118206
      Neurons depend on tightly regulated positioning of cellular components to maintain long-distance signaling, but the mechanisms guiding specific mRNAs to distant regions remain unclear. Here, we show that late endosomes function as selective RNA carriers in human motor neurons and uncover the molecular logic guiding their loading. Using APEX2-mediated proximity labeling, we identify the external transcriptome of RAB7A-positive endosomes and find a specific population of mRNAs enriched for endosomal, axonal, and synaptic functions. We find that mRNAs enriched in RAB7A endosomes contain evolutionarily conserved 5'UTRs that act as localization signals, and that the RNA-binding protein GEMIN5 interacts with these regions to promote endosomal RNA recruitment. Finally, we show that there is a conspicuous loss of endosome-associated transcripts in amyotrophic lateral sclerosis-associated conditions, accompanied by the mislocalization of GEMIN5 from endosomes. These findings uncover fundamental principles of RNA compartmentalization and highlight endosomal mRNA loading as a vulnerable axis in neuronal homeostasis.
    Keywords:  5'UTR; ALS; APEX2; CP: molecular biology; CP: neuroscience; FUS; GEMIN5; RAB7A; RNA compartmentalization; late endosomes; proximity labeling
    DOI:  https://doi.org/10.1016/j.celrep.2026.118206
  16. Cell Mol Neurobiol. 2026 Jul 29. pii: 156. [Epub ahead of print]46(1):
      Precise control of membrane protein localization and turnover is essential for synaptic function and circuit stability. Disruption of these processes alters the surface expression of receptors and transporters, ultimately impacting the excitatory/inhibitory (E/I) balance. Leucine-rich repeat kinase 2 (LRRK2) is emerging as a key regulator of these membrane-associated processes, acting at the interface between intracellular trafficking and synaptic signaling. LRRK2 integrates kinase activity with scaffolding functions to coordinate Rab-dependent vesicular trafficking, endosomal recycling, cytoskeletal dynamics, and endolysosomal pathways. Through these mechanisms, it controls the surface expression and distribution of synaptic receptors and neurotransmitter transporters in both neuronal and glial compartments. Pathogenic LRRK2 variants associated with Parkinson's disease (PD), converge on kinase hyperactivation and lead to sustained alterations in trafficking networks, resulting in selective mislocalization of membrane proteins. In this review, we examine how LRRK2-dependent trafficking mechanisms regulate key components of synaptic transmission, including glutamatergic and GABAergic receptors, as well as astrocytic transporters. We highlight how disruption of these processes affects neurotransmitter clearance, receptor activation, and ultimately E/I balance. Notably, accumulating evidence indicates that LRRK2 functions as an upstream coordinator of membrane organization at the crossroads of synaptic signaling and neurotransmitter homeostasis. Understanding how LRRK2 regulates trafficking pathways across cellular compartments provides mechanistic insight into circuit vulnerability in PD and highlights membrane-targeted strategies as potential approaches for restoring synaptic stability.
    Keywords:  Excitatory/inhibitory balance; GABA receptor; Glutamate receptor; Neurotransmitters transporters; Parkinson’s disease
    DOI:  https://doi.org/10.1007/s10571-026-01793-9
  17. Cell. 2026 Oct 28. pii: S0092-8674(26)01212-2. [Epub ahead of print]
      Huntington's disease (HD) affects the neocortex and striatum with different timing, severity, and gene-expression changes. These pathologies have long been proposed to involve different pathogenic mechanisms, with one brain area's degeneration leading to the other's. Striatal neurons degenerate in HD as their huntingtin (HTT) CAG-repeat tracts expand somatically beyond 150 CAGs. Here, we find that cortical pyramidal neurons in HD undergo biological changes analogous to those in striatal neurons-the same sequence of pathological phases, with toxicity also commencing at ∼150 CAGs but then changing their gene expression in distinct ways. Pyramidal neurons' precise molecular identities, rather than their areal or laminar locations, appeared to determine the extent of this somatic DNA-repeat expansion, which varied up to 20-fold among pyramidal neuron subtypes. Cortical and striatal neurons also shared a key pathological feature: nuclear inclusions of aggregated HTT protein in those nuclei with expansions well beyond 150 CAGs.
    Keywords:  DNA-repeat disorders; Huntington's disease; aggregation; cortex; huntingtin; nuclear inclusion; somatic instability; somatic mutation
    DOI:  https://doi.org/10.1016/j.cell.2026.10.001
  18. Cureus. 2026 Sep;18(9): e117043
      Amyotrophic lateral sclerosis (ALS) is characterized by prion-like propagation of misfolded TAR DNA-binding protein 43 (TDP-43) and superoxide dismutase 1 (SOD1) across motor neuron pools. Because any circulating pharmacological agent must cross the blood-brain and blood-spinal cord barriers (BBB and BSCB), this review proposes active craniospinal tensioning (ACT) as a mechanical, non-pharmacological route to disease modification that acts on cerebrospinal fluid (CSF) and venous pressure dynamics rather than requiring penetration of these barriers. ACT is proposed to engage a single Monro-Kellie/Queckenstedt pressure continuity through two concurrent mechanisms: suboccipital venous occlusion-rebound, hypothesized to transiently raise and release craniospinal CSF pressure via venous compression and thereby accelerate venous-side glymphatic efflux; and dural pull-recoil, hypothesized to generate a reciprocal CSF pressure gradient via spinal elongation, agitating perivascular CSF directly while inducing a coupled venous pressure gradient. Because both mechanisms act concurrently on a shared venous-side target, the combined maneuver is proposed to be more potent than either delivered alone, as in prior work on pelvis-stabilized axial spinal traction (PSAST), which lacks the occlusion-rebound component. A secondary, hypothesis-generating micro-biochemical axis, cerebral venous preconditioning (CVPC), proposes that the same occlusion-rebound cycle produces capillary/venule wall strain sufficient to activate heat shock factor 1 (HSF-1) across the neurovascular unit, independent of oxygen tension, with a possible but uncharacterized contribution from hypoxia-inducible factor 1-alpha (HIF-1α). The two routes are non-exclusive, with the macro-fluidic axis alone proposed as sufficient. This framework is entirely theoretical, requires preclinical and clinical validation, and is intended as a template for related proteinopathy-driven neurodegenerative diseases, including Parkinson's disease, Huntington's disease, spinocerebellar ataxia, and fatal familial insomnia, addressed in forthcoming work.
    Keywords:  active craniospinal tensioning (act); amyotrophic lateral sclerosis (als); blood-cns barrier (bcnsb); cerebral venous preconditioning (cvpc); dural pull-recoil; glymphatic-lymphatic clearance; heat shock factor 1 (hsf-1); sod1 proteinopathy; suboccipital venous occlusion-rebound; tdp-43 proteinopathy
    DOI:  https://doi.org/10.7759/cureus.117043
  19. Cell Rep. 2026 Oct 29. pii: S2211-1247(26)01207-6. [Epub ahead of print]45(11): 118128
      Gastaldo et al.1 report that lowering ataxin-2 protects neurons from TDP-43 toxicity in amyotrophic lateral sclerosis by activating neuronal glycolysis and astrocytic cholesterol synthesis, not by reversing TDP-43-dependent molecular pathology. The downstream effectors, IDH1 and HMGCS1, thus emerge as candidate therapeutic targets.
    DOI:  https://doi.org/10.1016/j.celrep.2026.118128
  20. Exp Dermatol. 2026 Nov;pii: e70379. [Epub ahead of print]35(11):
      Epidermal aging is characterized by impaired homeostasis, including reduced cell proliferation, aberrant differentiation, deterioration of the dermal-epidermal junction (DEJ), and compromised barrier function. Accumulating evidence suggests that these alterations arise not solely from intrinsic stem cell loss but from disruption of regulatory signalling networks governing epidermal function. In this study, we investigate whether inhibition of 3-phosphoinositide-dependent kinase-1 (PDK1), a central regulator of aging-related AKT/mTOR and NF-κB signalling, is associated with improved epidermal homeostasis through functional enhancement of autophagy. Using primary normal human epidermal keratinocytes (NHEKs) from young and old donors, 3-dimensional organotypic epidermal skin equivalents (SE), and chronologically aged human skin, we found that aged epidermis exhibited markedly reduced autophagy activity accompanied by defective differentiation, impaired keratinocyte proliferation, and loss of key stem cell niche components at the DEJ. Pharmacological inhibition of PDK1 using selective PDK1 inhibitors (BX795, GSK2334470) or a plant-derived inhibitor (kaempferol tetrasaccharide, KT1) formulated as Camellia japonica seed fraction (CF) suppressed AKT/mTOR and NF-κB signalling in aged keratinocytes, which was accompanied by increased autophagy-related markers and improved entry into differentiation. In addition, PDK1 inhibition increased basal keratinocyte proliferation, increased epidermal thickness, and improved DEJ components. In a proof-of-concept clinical study, topical application of CF, a botanical fraction containing KT1, was associated with improvements in epidermal autophagy, differentiation, DEJ integrity, and barrier function in aged human skin. Collectively, these findings identify a regulatory role of PDK1 within the epidermis and provide proof-of-concept evidence that pharmacological modulation of PDK1 activity exhibits potential for mitigating age-associated epidermal dysfunction.
    Keywords:  PDK1; autophagy; epidermal aging; epidermal homeostasis; kaempferol tetrasaccharide
    DOI:  https://doi.org/10.1111/exd.70379
  21. Acta Neuropathol Commun. 2026 Oct 28. pii: 226. [Epub ahead of print]14(1):
      Accumulation of misfolded SOD1 protein into intracellular aggregates, in the spinal cord (SpC) and brainstem, is a hallmark of amyotrophic lateral sclerosis caused by mutations in the SOD1 gene (SOD1-ALS). Two distinct aggregate conformations, denoted strain A and strain B, were identified in the CNS of SOD1G85R and SOD1D90A transgenic (Tg) ALS mouse models, respectively. Both strains transmit templated SOD1 aggregation and ALS-like disease in Tg mouse models when inoculated into the SpC, whereas muscle or intraperitoneal inoculations, of up to 300 times more inoculate, did not. Here, we used strain A and strain B aggregate seeds, prepared from SpCs of the Tg mice, to investigate strain-specific differences in transmission of templated aggregation and ALS phenotype via a peripheral nerve. We show that both strains can transmit templated aggregation to the CNS via the sciatic nerve in SOD1G85R Tg mice. Strain A resulted in shorter time to disease onset and earlier end-stage disease compared to strain B, and these strain-specific differences were accentuated in the sciatic nerve inoculation model compared to direct SpC inoculations. To further analyse the differences between strain A and strain B, we developed an immunohistochemical method that distinguishes the two SOD1 aggregate strains in tissue sections. This method revealed that strain B adopts an elongated, skein-like morphology, whereas strain A aggregates appear as accumulations of rounded, bead-like structures. These findings suggest that SOD1 aggregates forming in a peripheral nerve might transmit disease to the CNS and that different SOD1 aggregate strains can influence disease onset and progression. Our results warrant further exploratory studies of SOD1 aggregate conformations and their potential role in the manifestation of SOD1 mutant-specific disease phenotypes.
    Keywords:  ALS; Aggregate conformation; Amyotrophic lateral sclerosis; Motor neuron disease; Neurodegenerative disease; SOD1; Sciatic nerve; Strain morphology; Templated aggregation
    DOI:  https://doi.org/10.1186/s40478-026-02455-z
  22. bioRxiv. 2026 Sep 01. pii: 2026.08.27.747662. [Epub ahead of print]
      Tauopathies are characterized by the accumulation and spread of pathogenic tau aggregates throughout the brain, a process that is increasingly recognized to involve not only neurons but also microglia. However, whether pathogenic MAPT directly alters microglial degradative capacity remains poorly understood. Here, using isogenic human induced pluripotent stem cell-derived microglia carrying the pathogenic MAPT IVS10+16 mutation, we identify tau as a regulator of microglial lysosomal function. MAPT IVS10+16 microglia exhibited coordinated suppression of lysosomal and autophagic pathways, reduced lysosomal protease abundance and activity, and impaired autophagosome-lysosome fusion. Mutant microglia also showed reduced uptake of extracellular tau aggregates, reduced tau accumulation in acidic compartments, and a blunted lysosomal response to proteopathic stress. Conversely, genetic loss of MAPT increased lysosomal degradative capacity and accumulation of extracellular tau aggregates within acidic compartments, supporting a cell-intrinsic role for endogenous tau in regulating microglial degradative function. Pharmacologic enhancement of the autophagy lysosome pathway in MAPT IVS10+16 microglia increased proteolytic activity and improved tau handling. Together, these findings reveal a reciprocal relationship between tau and microglial lysosome function and identify degradative capacity as a modifiable component of the microglial response to tau pathology.
    DOI:  https://doi.org/10.64898/2026.08.27.747662
  23. Genes (Basel). 2026 Sep 24. pii: 1185. [Epub ahead of print]17(10):
      Background/Objectives: The ubiquitin proteasome system (UPS) serves critical cellular homeostatic functions that contribute to neurological health, including neuronal metabolism, synaptic plasticity, and the molecular circadian clock. The UPS is tightly regulated to ensure the correct balance of healthy proteins and those targeted for degradation and recycling; malfunction in this quality control process can contribute to disease states such as neurodegeneration and cancer. Target specificity in this system is due in part to ubiquitin ligase adaptor proteins, such as those of the BTB superfamily of proteins, which connect substrates to the larger proteasomal complex. In Drosophila, the BTB family member insomniac (human orthologs KTCD2, 5, and 17) has been shown to regulate sleep, arousal, and synaptic plasticity, but has not been examined for a role in neuronal excitability disease phenotypes. Methods: We utilized a genetic approach to interrogate neurobehavioral dysfunction in mitochondrial encephalomyopathy (ME) and the ability of dietary therapy to modulate this dysfunction. Results: Here, we report that genetic interference with insomniac modifies seizure-like behavior in a neuronal-subtype-specific manner in the ATP61 model of ME, ameliorating seizure severity when knocked down in GABAergic or dopaminergic neurons. Furthermore, while ATP61 typically responds to ketogenic dietary therapy with a robust reduction in seizure phenotype, we report that knockdown of insomniac or its binding partner Cullin RING Ligase 3 (Cul3) in neurons ablates this effect entirely, a previously unreported role for the UPS in downstream neurophysiological effects of the KD. Conclusions: These results implicate UPS BTB adaptor proteins as therapeutic targets in seizure pathology and identify them as a novel contributor to the ketogenic suppression of neuronal hyperexcitability. These two neurological roles are likely to be proceeding via cellular and molecularly distinct pathways, including a non-CRL3-based mechanism of seizure modulation.
    Keywords:  Cullin-3; advanced glycation end products (AGEs); epigenetics; insomniac; ketogenic diet; mitochondrial encephalomyopathy; seizures; ubiquitin proteasome system; β-hydroxybutyrylation
    DOI:  https://doi.org/10.3390/genes17101185
  24. Viruses. 2026 Sep 25. pii: 1065. [Epub ahead of print]18(10):
      HIV-associated neurocognitive disorders (HAND) can persist despite effective ART and are associated with persistent central nervous system (CNS) viral reservoirs in microglia, chronic neuroinflammation, synaptic dysfunction, and neuronal injury. Thus, human-relevant multicellular CNS models are needed to elucidate neuroHIV pathogenesis and ART neurotoxicity. Here, we establish and characterize a fully human induced pluripotent stem cell (hiPSC)-derived CNS tri-culture model comprising isogenic neurons, astrocytes, and microglia that remains viable and functionally active for up to 32 days in vitro. Using a microglia-tropic fluorescent HIV reporter virus, GFP-HIV-AD8, we demonstrate infection of IBA1+ microglia with no detectable infection of IBA1- cells or TUBB3+ neurons. HIV replication was quantified over 14 days post-infection and effectively suppressed by the first-generation integrase strand transfer inhibitor (INSTI)-containing regimen elvitegravir/tenofovir disoproxil fumarate/emtricitabine (EVG/TDF/FTC), and the second-generation INSTI-containing regimens dolutegravir/tenofovir disoproxil fumarate/emtricitabine (DTG/TDF/FTC) and bictegravir/tenofovir alafenamide/emtricitabine (BIC/TAF/FTC), at concentrations based on reported plasma Cmax values. HIV infection reduced microglial viability by approximately 70%, partially rescued by lower in vitro ART concentrations but worsened by the supratherapeutic 3× Cmax condition of DTG-containing regimens. In uninfected cultures, DTG induced microglial morphological changes consistent with a reactive or dysfunctional state. Calcium imaging revealed ART-specific neuronal effects: EVG/TDF/FTC reduced neuronal activity, whereas BIC/TAF/FTC enhanced it. In HIV-infected cultures, DTG shortened neuronal spike duration under viral suppression, identifying an HIV-DTG-associated electrophysiological phenotype. Overall, BIC/TAF/FTC showed the most favorable profile across the cellular and electrophysiological endpoints assessed in this donor line. Together, these findings establish an hiPSC-derived CNS tri-culture model for controlled studies of neuroHIV virology, ART effects, and neuronal function.
    Keywords:  antiretroviral therapy; bictegravir; dolutegravir; iPSC; microglia; morphology; neuroHIV; neuronal calcium; neurotoxicity; tri-culture
    DOI:  https://doi.org/10.3390/v18101065
  25. Front Neurol. 2026 ;17 1915238
       Background: Genetic factors are estimated to account for approximately 30-50% of the risk for developing Multiple sclerosis (MS). Distinct mitochondrial variants, impairments in the respiratory chain, and mitochondrial dysfunction have been reported in individuals affected by MS. Mitochondria and the endoplasmic reticulum (ER) form membrane contact sites (ERMCs) that control important biological functions. Dysregulated ERMCs have been associated with a number of severe consequences for homeostasis, including altered mitochondrial calcium levels, impaired ATP production and abnormal lipid transfer. All of these mechanisms are thought to play an important role in the pathogenesis and disease progression of MS. Here, we investigated the hypothesis that the mitochondrial predisposition plays a crucial role in contributing to MS development.
    Methods: Mitochondrial functionality was analyzed in a model of human induced primary neurons (iPNs), and neuronal precursor cells (NPCs), differentiated from induced pluripotent stem cells (iPSCs) from people with MS and healthy controls (HCs). Seahorse analysis was performed for investigation of the bioenergetic profile of the cells. ERMC and mitochondrial morphological analysis were carried out to investigate the potential impact of mitochondrial dysfunction in MS-derived neurons.
    Results: Seahorse analysis revealed significant differences in the respiratory complexes (spare capacity: p = 0.0002; non-mitochondrial oxygen consumption: p = 0.0207) and glycolysis (p = 0.0001; glycolytic reserve p = 0.0018) from MS-derived iPNs compared to HCs. We further investigated mitochondrial dysfunction in NPCs (maximal respiration p = 0.0491; non-mitochondrial oxygen consumption: p = 0.0226) and a significant difference in glycolytic reserve (p = 0.0359) from MS-derived NPC compared to HCs. Furthermore, we identified a significantly higher amount of ERMCs (p < 0.0001) and altered mitochondrial morphology in MS-derived iPNs compared to HC.
    Discussion: Our data are highlighting the importance of genetic mitochondrial contribution to MS pathology, by showing that MS-derived NPCs and iPNs exhibit altered mitochondrial behavior and morphology compared to healthy control (HC)-derived cells.
    Keywords:  endoplasmic reticulum; endoplasmic reticulum-mitochondria contacts; metabolism; mitochondria; multiple sclerosis
    DOI:  https://doi.org/10.3389/fneur.2026.1915238
  26. Front Aging. 2026 ;7 1971981
       Background: Human aging is characterized by a progressive, time-dependent deterioration in physiological and cognitive functioning. Aging is driven by an array of interconnected cellular hallmarks, including genomic instability, mitochondrial dysfunction, telomere attrition, epigenetic alteration and dysfunctional autophagy. Autophagy is a cytoprotective (cellular degradation and recycling) pathway that maintains homeostasis during starvation or stress, and whose activity is associated with extended lifespan. This multi-step process comprises autophagosome formation and maturation, autophagosome-lysosome fusion, and cargo degradation. Thus, analysis of autophagy flux is necessary to precisely design therapeutic interventions aimed at restoring autophagy in aging.
    Methods: The autophagy flux was comprehensively analyzed in human skin fibroblasts from donors of different ages (20-96 years old), a cell system that retains age-associated cellular and molecular signatures. The subcellular localization and activity of the master transcription factor of autophagy and lysosome biogenesis, TFEB, was analyzed by confocal microscopy assays and transcriptional expression of TFEB target genes (RT-qPCR) respectively. The autophagy flux was evaluated by monitoring the autophagy markers LC3 and p62 by Western blotting and confocal microscopy analyses, using inhibitor drugs to block autophagy or lysosomal activity. Autophagosome maturation and autophagosome-lysosome fusion were analyzed by colocalizing LC3 with Sintaxin-17 and LC3 with the lysosomal protein LAMP1 respectively, using inhibitor drugs and confocal microscopy assays. The analysis of lysosomal morphology and function was evaluated by lysobrite dye staining and live-cell confocal microscopy analysis.
    Results: The initial stages of autophagy, including activation of TFEB, and autophagosome formation, remained apparently functional in fibroblast aging. In contrast, the rate of both autophagosome maturation and autophagosome-lysosome fusion, as well as the lysosomal function appears to be altered in aged fibroblasts. Specifically, enlarged dysfunctional lysosomes were identified as a hallmark of the fibroblasts of the 96-year-old donor. This lysosomal dysfunction may lead to a reduced ability to degrade canonical autophagy markers, LC3-II and p62, and the accumulation of lipofuscin.
    Conclusion: Overall, the results provide evidence that autophagy flux is impaired at the late stages in aged fibroblasts, specifically in autophagosome maturation and autophagosome-lysosome fusion steps. Furthermore, it was demonstrated that this failure correlates with the presence of enlarged dysfunctional lysosomes. This study underscores the significance of enhancing lysosomal activity to counteract autophagy decline in aging.
    Keywords:  aging; autophagosomes; autophagy flux; fibroblast aging; lysosomes
    DOI:  https://doi.org/10.3389/fragi.2026.1971981
  27. Mol Neurobiol. 2026 Oct 28. pii: 998. [Epub ahead of print]63(1):
      Synucleinopathies, including Parkinson's disease, Dementia with Lewy bodies, and Multiple System Atrophy, are characterised by intracellular accumulation of misfolded α-synuclein (αSyn). Although αSyn aggregation is central to disease pathogenesis, the mechanisms linking αSyn to progressive neurodegeneration remain incompletely understood. Mitochondrial dysfunction is recognised as a key pathological process, particularly in experimental models using exogenously applied αSyn species, including preformed fibrils (PFFs). This systematic review synthesises evidence from mammalian in vitro studies that examined the effects of disease-associated αSyn conformations, including monomers, oligomers and PFFs, on mitochondrial structure and function. Following PRISMA 2020 guidelines, EMBASE, MEDLINE, and PsycInfo were searched to identify eligible peer-reviewed studies published up to March 2026, yielding 33 included studies. Models encompassed neuronal, astrocytic, microglial, endothelial, fibroblast, and induced pluripotent stem cell-derived systems, enabling comparison across cell types, αSyn conformations, and genetic backgrounds. Across included studies, oligomeric and fibrillar αSyn consistently induced mitochondrial depolarisation, impaired oxidative phosphorylation, reduced ATP production, complex-I dysfunction and increased reactive oxygen species generation. Additional mitochondrial pathological changes included fragmentation, cristae disruption, impaired TOM20-mediated protein import, calcium dysregulation, defective mitophagy and increased heteroplasmy i.e. accumulation of damaged mitochondria. These alterations frequently preceded cell death and were amplified in dopaminergic and genetically vulnerable models, including αSyn A53T, SNCA triplication, and PARK2-associated transgenic systems. Our review highlights mitochondrial dysfunction as a mechanism underlying αSyn toxicity, whilst suggesting methodological heterogeneity can limit cross-study translation. Priorities for future research using 'in vitro' models of PFF synucleinopathies include standardised fibril preparation protocols, improved mitochondrial phenotyping, and use of human multicellular and organoid models.
    Keywords:  Mitochondrial dysfunction; Neurodegeneration; Oxidative stress; Parkinson’s disease; Synucleinopathies; α-Synuclein
    DOI:  https://doi.org/10.1007/s12035-026-06287-9
  28. Open Biol. 2026 Oct 07. pii: 260209. [Epub ahead of print]16(10):
      Rare variants in NEK1, encoding a serine/threonine kinase, are among the most consistently implicated genetic contributors to amyotrophic lateral sclerosis (ALS), reported in approximately 2-3% of cases. Yet, while recent studies have characterized the cell biological consequences of NEK1 loss-of-function, the biochemical effects of ALS-associated missense variants on kinase activity have not been directly investigated. This distinction is mechanistically important, because missense alleles encode mutant proteins rather than simply reducing protein dosage. Here, we provide the most comprehensive cell-based phosphoproteomic map of NEK1 phosphorylation to date, identifying 10 recurrent phosphorylation sites across independent expression and acquisition conditions. We experimentally assign pSer14, pThr156 and pSer418 as NEK1 autophosphorylation sites using kinase-dead controls, targeted extracted ion chromatogram analysis, phosphosite mutagenesis and phosphospecific antibodies. Leveraging activation-loop pThr156 as a read-out of NEK1 activity, we assessed nine ALS-associated missense variants spanning the major functional regions of the protein. Among catalytic-domain variants, R261C produced the most robust reduction in pThr156 autophosphorylation, R232C produced a smaller reduction, and R232H increased pThr156; the basic-region variant, A313T, also showed a smaller reduction. Structural modelling provides a mechanistic framework for understanding these variant-specific effects. Our study establishes the first activity-based framework for functional classification of NEK1 missense variants, and provides direct evidence that ALS-associated missense variants can alter NEK1 autophosphorylation through a mechanism distinct from simple haploinsufficiency. The phosphospecific antibodies, isogenic cell lines and curated phosphoproteomic datasets generated here provide a community resource for future studies of NEK1 regulation, variant interpretation and therapeutic target validation.
    Keywords:  NEK1 kinase; amyotrophic lateral sclerosis; autophosphorylation; motor neuron disease
    DOI:  https://doi.org/10.1098/rsob.260209
  29. bioRxiv. 2026 Oct 08. pii: 2026.10.06.757033. [Epub ahead of print]
      Sporadic disease accounts for about 90% of amyotrophic lateral sclerosis (ALS) cases, and its biological heterogeneity is a major contributor to the failure of trials that enroll patients under a single diagnosis. Because sporadic ALS lacks a shared genetic anchor, identifying biological signals is critical for effective patient stratification. We analyzed induced pluripotent stem cell-derived motor neurons from 619 AnswerALS participants using transcriptomics, proteomics, and whole-genome sequencing and identified CCT2 as the first single-gene marker of a molecular state within sporadic ALS, providing a measurable basis for trial enrollment according to biology. We first anchored the analysis in known ALS genotypes. C9orf72 and SOD1 motor neurons did not converge on a common signature but retained genotype-specific differences that bulk postmortem tissue compresses. Scoring 391 sporadic patients along three transcriptomic axes (bioenergetic stress, cell cycle, and inflammation) resolved three states. One state was marked by CCT2, a TRiC chaperonin subunit, which distinguished it from the quiescent state with an area under the curve of 0.892. CCT2 was also elevated at the protein level and associated with the rate of ALSFRS-R decline, although this association weakened after adjustment for culture composition. Upstream regulator analysis placed this state downstream of MYC and mTORC1 activation. No germline test across 360 whole genomes explained these states. Validation using Target ALS data showed that the relationship between CCT2 and the cell cycle program was also present in postmortem cortex enriched for layer 5b projection neurons.
    DOI:  https://doi.org/10.64898/2026.10.06.757033
  30. Biochem Biophys Res Commun. 2026 Oct 23. pii: S0006-291X(26)01561-5. [Epub ahead of print]841 154795
      Glycogen molecules deficient in α1:6 glycosidic bonds (branch points) must be eliminated rapidly from cells, otherwise they accumulate and precipitate causing human disease, but how unbranched glycogen is marked selectively for destruction is unclear. We report here that unbranched glycogen is polyubiquitylated in glycogen branching enzyme knockout HEK293T cells, but normally branched glycogen in wild-type cells is not. The polyubiquitin liberated from unbranched glycogen by incubation with hydroxylamine or digestion with α-amylase was similar in size and quantity, indicating that polyubiquitin is linked to unbranched glycogen by an ester bond(s). The ubiquitin molecules forming the polyubiquitin were linked predominantly via Met1, Lys11 and Lys48 of ubiquitin, with smaller amounts linked via Thr12 and Ser20 of ubiquitin. We also report that glycogenin-1, the enzyme that initiates glycogen synthesis, is attached to unbranched glycogen covalently and ubiquitylated at Lys342 and Lys344. Our study has established that polysaccharides can be ubiquitylated in cells as well as proteins. We suggest that polyubiquitylation marks unbranched glycogen for uptake into lysosomes and discuss the E3 ligases that may participate in the polyubiquitylation of unbranched glycogen and glycogenin-1.
    Keywords:  Glycogen; Glycogenin; HOIL-1; HOIP; LUBAC; Ubiquitin
    DOI:  https://doi.org/10.1016/j.bbrc.2026.154795
  31. Autophagy. 2026 Oct 28. 1-14
      The condition of having a healthy, functional proteome is known as protein homeostasis, or proteostasis. Establishing and maintaining proteostasis is the province of the proteostasis network, a highly interconnected system of over 3000 components that regulate protein synthesis, folding, localization, and degradation. The proteostasis network is a fundamental functional unit in biology that is essential for cellular health and has direct relevance to many diseases of protein conformation. However, it is not well defined or annotated, hindering its functional characterization in health and disease. In this series of manuscripts, we aim to operationally define the human proteostasis network by providing a comprehensive, annotated list of its components. In the other manuscripts in this series, we survey the components of the proteostasis network that make up (1) the machineries for protein synthesis, protein folding, protein trafficking into and out of organelles, and organelle-specific degradation pathways and (2) the ubiquitin-proteasome system. Here, we have compiled a curated list of over 850 unique high-confidence components of the autophagy-lysosome pathway, the other major protein degradation system in human cells. This resource will facilitate the rigorous investigation of autophagy-lysosome pathway dysfunction as a driver of proteostasis imbalance in aging and disease.
    Keywords:  Aging; annotation; degradation; lysosomal catabolism; neurodegenerative disease; systems
    DOI:  https://doi.org/10.1080/15548627.2026.2741038
  32. Autophagy. 2026 Oct 31. 1-3
      Macroautophagy/autophagy maintains cellular homeostasis by delivering cytoplasmic cargo to lysosomes for degradation. Autophagosome formation requires a substantial supply of phospholipids, mainly supported by the lipid scramblase ATG9A and lipid-transfer proteins ATG2A and ATG2B. Our recent study shows that loss of these proteins also alters small extracellular vesicle (sEV) secretion and composition. Cells lacking ATG9A or ATG2A/B release more sEVs during lysosomal inhibition, yet these vesicles contain less microtubule-associated protein 1A/1B-light chain 3 (LC3) and canonical autophagy cargo receptors. These changes are accompanied by impaired amphisome formation and extensive remodeling of the cellular lipidome. Our findings suggest that ATG9A and ATG2A/B coordinate membrane and cargo distribution between autophagy and endosomal secretion, raising the possibility that disrupted lipid supply to autophagosomes redirects lipids toward extracellular vesicle (EV) biogenesis.
    Keywords:  ATG2A/B; ATG9A; Amphisomes; extracellular vesicles; lipid homeostasis
    DOI:  https://doi.org/10.1080/15548627.2026.2752748
  33. J Hum Genet. 2026 Oct 27.
      Traditionally conceptualized as a soma-centric pathology, amyotrophic lateral sclerosis (ALS) is a fatal, heterogeneous neurodegenerative disease. The suboptimal outcomes of central nervous system (CNS)-directed therapeutic strategies have necessitated a shift in focus toward the dying-back hypothesis. This hypothesis contends that synaptic disconnection and axonal retraction at the distal neuromuscular junction (NMJ) are early pathological events that may antedate overt motor neuron loss. This review systematically examines the NMJ as an early vulnerable and therapeutically tractable peripheral niche in ALS pathogenesis, rather than merely a downstream consequence of proximal proteinopathy. Evidence from human clinical samples and ALS mouse models, particularly SOD1-G93A mice, collectively supports the early vulnerability of the NMJ, with the temporal precedence of denervation, synaptic retraction, and mitochondrial dysfunction most clearly demonstrated in experimental models. We highlight how the breakdown of the tripartite synapse-comprising the motor terminal, skeletal muscle, and terminal Schwann cells (tSCs)-may disrupt essential neurotrophic signaling and local metabolic homeostasis. Furthermore, we discuss how advancements in humanized in vitro NMJ models and spatial transcriptomics provide unprecedented resolution into localized RNA dysmetabolism and bioenergetic failure. Finally, we evaluate emerging therapeutic strategies specifically designed to stabilize or restore the NMJ, including MuSK agonists and other NMJ-directed approaches. By recontextualizing the NMJ as a critical early site of vulnerability, we propose that targeting the peripheral synaptic microenvironment may offer a promising strategy for modifying the progression of ALS.
    DOI:  https://doi.org/10.1038/s10038-026-01522-6
  34. Front Cell Neurosci. 2026 ;20 1864654
       Introduction: The altered myelin repair observed in demyelinating diseases such as multiple sclerosis (MS) potentially exposes axons to various stressors, with consequent neurodegeneration. Preclinical evidence has demonstrated that Bruton's tyrosine kinase inhibitors (BTKi), such as ibrutinib, delay MS progression by acting on myeloid cells.
    Methods: We investigated the effects of ibrutinib on remyelination using a novel in vitro model of spinal cord neurons derived from postnatal mice.
    Results: We demonstrated that (1) spinal cord neuron cells represent a suitable model for investigating myelination following L‑α‑lysophosphatidylcholine (LPC) treatment; (2) ibrutinib induces remyelination and reduces stathmin‑1 expression in spinal cord cultures; and (3) ibrutinib reduces the inflammatory phenotype of microglia‑like BV2 cells, thereby modulating the expression of miR‑223 in extracellular vesicles (EVs).
    Discussion: Altogether, these data pave the way for a better understanding of the mechanisms underlying remyelination following ibrutinib treatment and support the hypothesis that EV‑derived microglial cells play a key role.
    Keywords:  Bruton's tyrosine kinase; cellular communication; inflammation; microglia; neuroprotection
    DOI:  https://doi.org/10.3389/fncel.2026.1864654
  35. bioRxiv. 2026 Oct 06. pii: 2026.10.05.756807. [Epub ahead of print]
      Pathological tau disrupts neuronal activity and brain function in Alzheimer's disease and other tauopathies. However, the underlying mechanisms for neuronal network dysfunction remain largely unknown. Using human inducible pluripotent stem cell (iPSC) - derived neurons, we show that the familial MAPT P301L mutation leads to neuronal network hyperexcitability. Imbalanced excitation and inhibition were attributable to neuronal subtype-specific tau pathology that was associated with different alterations of tau interactomes in excitatory versus inhibitory neurons. Suppressing enhanced excitatory synaptic transmission or blocking Ca 2+ influx resulting from enhanced P301L tau/AHNAK interaction in inhibitory neurons rescued the neuronal network hyperexcitability. This study expands our understanding on how disease-causing tau mutations alter the excitatory/inhibitory balance, leading to network dysfunction in human neurons.
    HIGHLIGHTS: The FTD-causing P301L tau mutation leads to neuronal network hyperexcitability.P301L tau causes hyperactivity of excitatory neurons while hypoactivity of inhibitory neurons.Tau and P301L tau interactomes differ in excitatory vs. inhibitory neurons.Enhanced excitatory synaptic transmission and P301L tau/AHNAK interaction in inhibitory neurons contribute to neuronal network hyperexcitability.
    Graphic Summary:
    DOI:  https://doi.org/10.64898/2026.10.05.756807
  36. Biochemistry (Mosc). 2026 Oct;91(10): 1798-1821
      Mitochondria, acquired during the evolution of eukaryotic cells, have become essential organelles for cellular life. Beyond their well-established role in energy production, mitochondria are key regulators of intracellular signaling, acting as modulators of Ca2+ transport and major sources of reactive oxygen species. Mitochondrial metabolism is also closely linked to the metabolism of signaling molecules, including glutamate and monoamines. Another vital role of mitochondria is their involvement in the regulation of cell death. Disruption of mitochondrial functions contributes to the development of multiple pathological conditions, including neurodegenerative diseases. Here, we discuss how impairments in major mitochondrial processes contribute to neuronal death in neurodegenerative diseases and highlight the principal mitochondrial targets with potential pharmacological relevance.
    Keywords:  bioenergetics; calcium homeostasis; cell death; mitochondria; mitochondrial dynamics; neurodegeneration
    DOI:  https://doi.org/10.1134/S0006297926601826
  37. Nat Commun. 2026 10 28. pii: 11036. [Epub ahead of print]17(1):
      Genetic modifiers of Huntington's disease (HD) disease onset and progression implicate somatic instability (SI) of the expanded CAG repeat as a key pathogenic driver, with MSH3 emerging as a therapeutic target. Here, we generated a computational model that uses HD patient data to infer therapeutic effects of reducing SI and in parallel designed an artificial miRNA to lower MSH3 mRNA (miMSH3) after delivery with AAV-DB-3, a previously described medium spiny neuron (MSN)-targeting AAV capsid variant. AAV-DB-3.miMSH3 achieved 48-94% MSH3 mRNA reduction in MSNs of nonhuman primates (NHPs), which when applied to predictive modeling predicts 50-120 % slowing of HD progression as measured by change from baseline in the composite Unified Huntington Disease Rating Scale. Additionally, AAV-DB-3.miMSH3 reduced SI reduction by up to 46% in HdhQ111 mice. Cumulatively, the preclinical experimental data and the computational model support the translational potential of AAV-DB-3.miMSH3 as a disease-modifying therapy for HD.
    DOI:  https://doi.org/10.1038/s41467-026-78769-2
  38. Science. 2026 Oct 29. 394(6823): eaed2525
      Targeted protein degradation is a promising modality to treat cancer or inflammation, but whether it can provide a similar benefit for disorders caused by pervasive protein dysregulation is unclear. We describe stimulated protein degradation (SPD) as a strategy that leverages agonists of stress-responsive E3 ubiquitin ligases to simultaneously eliminate multiple pathogenic factors. Specifically, we show that activators of the reductive stress response E3 CUL2FEM1B boost degradation of multiple physiological substrates to improve mitochondrial import and electron transport chain assembly. In this manner, CUL2FEM1B agonists preserve mitochondrial function and neuronal survival in models of neurodegenerative COX deficiency syndrome and Friedreich's ataxia. By activating E3 ligases that evolved to safeguard cellular integrity, SPD expands the use of compound-induced protein degradation to complex pathologies of high unmet need.
    DOI:  https://doi.org/10.1126/science.aed2525